Scinai Immunotherapeutics (SCNI) Cash from Operations (2018 - 2026)
Scinai Immunotherapeutics (SCNI) posted Cash from Operations of 1456000.0 for Q1 2026, up 5.08% sequentially from 1534000.0 in Q2 2025, and down 39.87% YoY from 2421239.62 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Cash from Operations (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Cash from Operations for 9 years, with the latest figure at 1456000.0 in Q1 2026.
- Quarterly Cash from Operations fell 39.87% year-over-year to 1456000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5107000.0 (up 13.63% YoY) and the FY2025 annual result came in at 6031000.0, up 4.8% from the prior year.
- Cash from Operations rose to 1456000.0 in Q1 2026 per SCNI's latest filing, from 1534000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 593000.0 in Q4 2022 and troughed at 3665000.0 in Q2 2022.
- A 5-year average of 1800866.67 and a median of 1534000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 69.26% in 2022, then plunged 176.83% in 2023.
- Over 5 years, Cash from Operations stood at 593000.0 in 2022, then plunged by 106.58% to 1225000.0 in 2023, then gained by 12.16% to 1076000.0 in 2024, then plunged by 42.57% to 1534000.0 in 2025, then advanced by 5.08% to 1456000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1456000.0, 1534000.0, and 1041000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -2.88 Mn |
| Jun 30, 2023 | -2.88 Mn |